NMN and kidneys research does not establish that taking an NMN supplement improves kidney function. For readers in the US, a small human trial found increased blood NAD+ without a significant kidney-marker benefit. Kidney disease, abnormal bloodwork or a transplant calls for clinician review—not a supplement experiment based on animal research.
What does the human NMN kidney trial actually show?
The clearest distinction is between raising NAD+ and improving kidney outcomes. Those are different endpoints, and success at the first does not establish the second.
A randomized trial of MIB-626, an NMN formulation, enrolled 42 hospitalized adults with COVID-19 and acute kidney injury. Participants received the study formulation or placebo over 14 days. Blood NAD+ increased with treatment, but changes in creatinine and other kidney-related markers did not show a statistically significant treatment advantage.
The study matters because it measured people with an actual kidney problem rather than relying only on laboratory models. Its limits matter just as much: this was a small, short trial in a specific hospital population. It was not a study of everyday NMN use by otherwise healthy shoppers, nor a trial of AgeAura NMN + TMG.
The authors reported no clinically important between-group differences in laboratory safety measures. However, adverse events occurred in both groups, and the trial was not large enough to establish broad or long-term safety. “No clear benefit” should not become “NMN damages kidneys,” and a reassuring laboratory comparison should not become “safe for every kidney patient.” Both shortcuts go beyond the evidence.
Why do animal findings not settle NMN kidney safety?
Animal findings can motivate human research; they cannot tell an individual whether a retail supplement is safe or effective. The human trial's background describes preclinical evidence behind studying NAD+ augmentation in kidney injury. Its human results did not reproduce a clear kidney-marker benefit.
A useful reading habit is to identify the population before reading the headline. Was the experiment conducted in cells, mice, hospitalized adults or healthy volunteers? Then identify the endpoint: blood NAD+, a laboratory marker, symptoms or a clinically meaningful outcome. A result in one category cannot simply be moved into another.
For an NMN kidney disease claim, ask whether the participants had the same condition you have. Acute illness in a hospital is not interchangeable with stable chronic kidney disease. Also ask whether the exact formulation was tested. A study of an NMN formulation does not automatically validate a retail combination containing NMN and TMG.
How should you read creatinine and eGFR results?
Creatinine and eGFR help clinicians assess filtration; neither is a personal score for whether NMN is working. The NIDDK guide to kidney tests explains that creatinine is a waste product from muscle breakdown and that blood creatinine helps estimate glomerular filtration rate, or eGFR.
NIDDK also describes urine albumin testing. Albumin leaking into urine can signal kidney damage, so a blood result alone is not the whole assessment. Your clinician can explain which tests apply to you and whether an unexpected result needs repeating.
| Evidence or test | What it can tell you | What it cannot establish alone |
|---|---|---|
| Increased blood NAD+ in the NMN trial | The study formulation changed that biochemical endpoint | Better kidney function or protection from kidney disease |
| Blood creatinine and calculated eGFR | Information about kidney filtration | That a supplement caused a change |
| Urine albumin testing | Whether albumin is appearing in urine | Whether an NMN product is appropriate for you |
| Short-term trial safety observations | What happened in that study population during follow-up | Long-term safety for every shopper |
Sources: MIB-626 trial and NIDDK testing guidance.
If a lab result changes after starting a supplement, bring the product label and start date to the clinician interpreting it. Do not assume either that NMN caused the result or that the change is harmless. Avoid adjusting prescribed treatment to make room for a supplement.
Who should ask a clinician before considering NMN?
Anyone with known kidney disease or unexplained abnormal kidney tests should make this a medical-review question before a buying decision. This is a precaution based on the limits of the evidence, not a claim that the trial proved NMN harmful.
For dialysis patients, transplant recipients and people under active kidney care, this article cannot supply personal clearance. The hospital trial excluded people with a baseline eGFR below 30; its findings therefore cannot establish safety for that excluded group. See the trial eligibility criteria rather than treating the headline as permission.
Prepare a short appointment list:
- Bring the full ingredient panel, not just a screenshot of the product name.
- List prescription medicines, other supplements and when each was started.
- Ask whether your existing kidney results change the decision to use NMN.
- Ask whether any follow-up testing is appropriate for your situation.
- Clarify what to do if symptoms or bloodwork change; do not invent a monitoring schedule yourself.
For a separate medication question, read NMN and metformin: human data. That discussion is not an interaction clearance for your own prescription list.
What should buyers in the US check about NMN plus TMG?
A combination label identifies the product; it does not establish a kidney benefit. Wellness Nest lists AgeAura Pure NMN + TMG NAD+ Complex at $79.99 when checked for this article. The packaging identifies NMN + TMG and vegan capsules. Neither the name nor the price is evidence of renal safety.
The cited kidney trial did not test this retail product. Do not read its results as a claim that adding TMG protects kidneys, improves eGFR or makes NMN suitable for someone with kidney disease. A combination needs its own evidence for any combination-specific claim.
Before ordering, compare the actual label with the listing and ask for documentation relevant to the batch. Do not infer independent testing from a white bottle, a scientific-sounding name or a general wellness statement. If your clinician needs details that are not available, resolve that gap before purchasing.
Review the AgeAura product listing
The store's best-seller collection and men's essentials collection are broader shopping directories, not kidney-safety recommendations or a claim that AgeAura belongs to either collection. A collection placement cannot answer a medical suitability question.
What to ask next
For the broader routine question, see How to Take NMN: A Capsule Routine in the US. Keep routine advice separate from the unresolved question of whether NMN is appropriate for your kidney history.
Frequently Asked Questions
Is NMN safe for kidneys?
The available trial discussed here cannot establish universal safety. It found no clinically important laboratory safety differences between groups during short follow-up, but studied a small, specific hospital population. People with kidney disease should seek individualized advice before using NMN rather than treating that finding as clearance.
Does NMN lower creatinine?
The cited randomized kidney trial did not demonstrate a statistically significant treatment advantage for creatinine. A lower personal test result would not, by itself, prove an NMN effect. Discuss results and their trend with the clinician who ordered the tests.
Can NMN treat chronic kidney disease?
The evidence presented here does not establish NMN as a treatment for chronic kidney disease. Do not replace prescribed kidney care with NMN, or assume that animal findings demonstrate a benefit in people.
Is NMN with TMG better for kidneys than NMN alone?
The cited trial does not answer that comparison. It did not test AgeAura NMN + TMG against NMN alone. A combination's ingredient list is not evidence that it improves kidney outcomes or removes uncertainty about safety.
Where can I buy AgeAura NMN plus TMG in the US?
The product is listed online at Wellness Nest through the AgeAura link above. Check the current price and full product information before ordering. If kidney disease or abnormal tests prompted your search, have the suitability conversation before the purchase—not after opening the bottle.
About the Author
Dr. Marcus Hale is the resident health researcher behind Wellness Nest's editorial team, translating peer-reviewed sports-nutrition and longevity research into practical daily guidance for US readers.
